Statement Of Cash Flows [Abstract]

Ascelia Pharma - Filing #689421

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
SEK
131 223 SEK
131 223 SEK
131 223 SEK
SEK
SEK
SEK
SEK
SEK
SEK
125 903 SEK
SEK
125 903 SEK
125 903 SEK
Adjustments to reconcile profit (loss) [abstract]
Adjustments for increase (decrease) in trade accounts payable
9 722 SEK
2 258 SEK
Adjustments for share-based payments
1 627 SEK
5 919 SEK
Other adjustments for non-cash items
1 091 SEK
1 045 SEK
Interest paid, classified as operating activities
48,000 SEK
77,000 SEK
Interest received, classified as operating activities
635,000 SEK
10,000 SEK
Income taxes paid (refund), classified as operating activities
3 772 SEK
1 020 SEK
Cash flows from (used in) operating activities
125 263 SEK
116 559 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
SEK
38,000 SEK
Cash flows from (used in) investing activities
65,000 SEK
38,000 SEK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
1 016 SEK
944,000 SEK
Cash flows from (used in) financing activities
1 100 SEK
184 871 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
126 428 SEK
68 274 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
14 384 SEK
8 639 SEK
Cash and cash equivalents
149 555 SEK
261 599 SEK
184 686 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.